Figure 3.
Figure 3. Cumulative-incidence curves of time-to-first infection stratified by baseline characteristics. (A-C) Cumulative incidences of any infection within 28 days after CAR–T-cell infusion stratified by underlying disease (A), number of prior antitumor treatment regimens (B), and CAR–T-cell dose of 2 × 105 cells per kg (dose level 1), 2 × 106 cells per kg (dose level 2), or 2 × 107 cells per kg (dose level 3) (C). P values are derived from adjusted Poisson regression (Table 3). Dotted lines represent the 95% CIs. DL, dose level; Ptx, prior therapy.

Cumulative-incidence curves of time-to-first infection stratified by baseline characteristics. (A-C) Cumulative incidences of any infection within 28 days after CAR–T-cell infusion stratified by underlying disease (A), number of prior antitumor treatment regimens (B), and CAR–T-cell dose of 2 × 105 cells per kg (dose level 1), 2 × 106 cells per kg (dose level 2), or 2 × 107 cells per kg (dose level 3) (C). P values are derived from adjusted Poisson regression (Table 3). Dotted lines represent the 95% CIs. DL, dose level; Ptx, prior therapy.

Close Modal

or Create an Account

Close Modal
Close Modal